Modern Retina

CONTINUE TO SITE

OR WAIT null SECS

AMD Insights Video Series Diabetic Macular Edema Retina in 2020 Updates from Angiogenesis 2021 Retina Disorders Wet AMD Wet AMD Viewpoint Diabetic Eye Disease Viewpoint Ang2 inhibition for retinal disease

AMD Insights Video Series Diabetic Macular Edema Retina in 2020 Updates from Angiogenesis 2021 Retina Disorders Wet AMD Wet AMD Viewpoint Diabetic Eye Disease Viewpoint Ang2 inhibition for retinal disease

View More AMD Diabetic Macular Edema Diabetic Retinopathy Imaging Ophthalmology Retinal Surgery Uveitis

AMD Diabetic Macular Edema Diabetic Retinopathy Imaging Ophthalmology Retinal Surgery Uveitis

Expert Interviews

Medical World News

Updates From Angiogenesis 2021

Expert Interviews Insights Medical World News Podcasts Rapid Readouts Updates From Angiogenesis 2021 Viewpoints

Conference Coverage

Conference Listing

Conference Coverage Conference Listing

Research Scholar Honoree Program

Resident Writer

Residents Research Scholar Honoree Program Resident Writer

Modern Retina Digital Edition

Sponsored Resources

CME/CE Sponsored Resources

Advertise
Contact Us
Terms and Conditions
Privacy
Do Not Sell My Personal Information

© 2021 MJH Life Sciences and Modern Retina. All rights reserved.

.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Spotlight

AMD Insights Video Series
Diabetic Macular Edema
Retina in 2020
Updates from Angiogenesis 2021
Retina Disorders
Wet AMD
Wet AMD Viewpoint
Diabetic Eye Disease Viewpoint
Ang2 inhibition for retinal disease

ClinicalSee All >

AMD
Diabetic Macular Edema
Diabetic Retinopathy
Imaging
Ophthalmology
Retinal Surgery
Uveitis

Advertise
Contact Us
Terms and Conditions
Privacy
Do Not Sell My Personal Information

© 2021 MJH Life Sciences^™ and Modern Retina. All rights reserved.

Munir Escaf, MD

home

Articles

Laser therapy may offer fast-acting option for CSR resolution

November 12, 2018

Article

Patients tolerate therapy well; high safety profile allows re-treatment as necessary